Delivery Order SPE2DB24D9238-SPE2DB25FDRBK
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Vabysmo 6 mg/0.05 mL syringes valued at $4,475.16. The award, issued on July 31, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. This delivery order does not utilize a set-aside designation and represents a continuation of the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,950.32 by the Defense Logistics Agency (DLA) on June 5, 2025. The contract calls for the delivery of Vabysmo 6 mg/0.05 mL syringes, a pharmaceutical product used in ophthalmology treatment. This delivery order represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,933.76 on July 18, 2025, for the supply of Vabysmo 6 mg/0.05 mL syringes. The award carries an ultimate completion date of August 8, 2025, and represents a specific delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $29.8K on July 21, 2025, for the supply of Vabysmo 6 mg/0.05 mL syringes. This firm fixed-price delivery order is set to be completed by August 11, 2025, and represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program. The parent contract,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,966.88 by the Defense Logistics Agency (DLA) on September 5, 2025. The contract calls for the delivery of Vabysmo 6 mg/0.05 ml syringes, a prescription medication used in ophthalmic treatment. The order has an ultimate completion date of September 26, 2025, and carries no set-aside designation. This delivery order falls...
- The Defense Logistics Agency (DLA), functioning as part of the Department of Defense's Medical Supply Chain, awarded a delivery order valued at $8,655.50 to DMS Pharmaceutical Group Inc. for the supply of VABYSMO 6MG/0.05ML. This firm fixed-price delivery order, issued on June 25, 2025, with an ultimate completion date of the same day, represents a discrete pharmaceutical product delivery under DMS Pharmaceutical Group's larger indefinite delivery contract with the DLA. The award was made...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,966.88 by the Defense Logistics Agency (DLA) on August 14, 2025. The delivery order, which must be completed by September 5, 2025, covers the supply of VABYSMO 6 mg/0.05 ml syringes (0.05 ml units), an injectable pharmaceutical product. This award was issued without a set-aside designation, allowing the vendor to compete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,922.15 on September 19, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as a firm fixed-price delivery order with no set-aside designation, calls for the delivery of Vabysmo 6mg/0.05ml, a pharmaceutical product for federal healthcare systems. Performance is scheduled to be completed by...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,983.44 by the Defense Logistics Agency (DLA) on June 2, 2025. The contract calls for the delivery of Vabysmo 6 mg/0.05 mL syringes (0.05 mL) with an ultimate completion date of June 24, 2025. This delivery order was issued without a set-aside designation and represents a single-line procurement of this pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $14,584.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Vabysmo 6 mg/0.05 ml vials. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, does not utilize any set-aside designation. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDRBKDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $14,917.20 by the Defense Logistics Agency (DLA) on September 15, 2025. The delivery order, which has an ultimate completion date of October 6, 2025, covers the supply of Vabysmo 6 mg/0.05 mL syringes for delivery to Park Ridge, Illinois. This award was issued without a set-aside designation, allowing the contractor to compete on an unrestricted basis. The delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical supplies supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with the DLA for an extensive portfolio of prescription medications, biologics, and medical consumables. The company's federal contracting portfolio demonstrates its capability to distribute specialized pharmaceutical products, including oncology treatments, vaccines, and injectable medications to Department of Defense healthcare facilities. This particular delivery order for Vabysmo, a prescription ophthalmic injection used in the treatment of age-related macular degeneration, represents the contractor's continued role in supplying specialty pharmaceutical products to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 9/15/25 |